top of page
These interviews and transcripts are provided for educational and informational purposes only. They reflect the views of the individual speaker at the time of the interview and do not constitute clinical guidelines, standards of care, or individualized medical advice. Readers should consult qualified clinicians and current medical literature when making clinical or treatment decisions. Content should not be presented as definitive guidance or used out of context in publications, policy statements, or clinical materials.

Gregory Fricchione, M.D.
Dr. Gregory Fricchione is on the faculty at Harvard Medical School. He is also Associate Chief of Psychiatry at Massachusetts General Hospital (MGH), Director if the Division of Psychiatry and Medicine at MGH, the MGH Psychosomatic Medicine Fellowship Program, the Spaulding Rehabilitation Hospital Behavioral Mental Health Service, and of the Benson-Henry Institute for Mind Body Medicine at MGH.
Gregory Fricchione, M.D.
1. Dr. Gregory Fricchione Introduction

Search video...

1. Dr. Gregory Fricchione Introduction
01:15

2. What is catatonia?
06:41

3. What causes catatonia?
02:26

4. Why do so many physicians struggle to recognize catatonia?
01:40

5. How is the stress response different in a person with catatonia?
03:26

6. How does mixed catatonia work?
02:08

7. How did Lorazepam become the treatment of choice for catatonia?
04:54

8. How did you become interested in catatonia?
02:59

9. Addressing proper dosage of lorazepam for catatonia patients
01:41

10. Why is lorazepam less effective when treating catatonia in autism?
04:28

11. What is ECT?
05:00

12. What do you hope The Catatonia Foundation can accomplish?
02:20
bottom of page
